KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Net Income towards Common Stockholders: 2009-2025

Historic Net Income towards Common Stockholders for Thermo Fisher Scientific (TMO) over the last 17 years, with Sep 2025 value amounting to $1.6 billion.

  • Thermo Fisher Scientific's Net Income towards Common Stockholders fell 1.10% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 billion, marking a year-over-year increase of 7.58%. This contributed to the annual value of $6.3 billion for FY2024, which is 5.67% up from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Net Income towards Common Stockholders is $1.6 billion, which was down 2.42% from $1.7 billion recorded in Q2 2025.
  • Over the past 5 years, Thermo Fisher Scientific's Net Income towards Common Stockholders peaked at $2.3 billion during Q2 2021, and registered a low of $1.3 billion during Q2 2023.
  • Its 3-year average for Net Income towards Common Stockholders is $1.6 billion, with a median of $1.6 billion in 2025.
  • Per our database at Business Quant, Thermo Fisher Scientific's Net Income towards Common Stockholders spiked by 196.57% in 2021 and then slumped by 41.81% in 2023.
  • Over the past 5 years, Thermo Fisher Scientific's Net Income towards Common Stockholders (Quarterly) stood at $1.7 billion in 2021, then dropped by 4.95% to $1.6 billion in 2022, then increased by 3.43% to $1.6 billion in 2023, then grew by 12.27% to $1.8 billion in 2024, then dropped by 1.10% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.7 billion for Q2 2025, and $1.5 billion during Q1 2025.